Compare CLMB & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLMB | NPCE |
|---|---|---|
| Founded | 1982 | 1997 |
| Country | United States | United States |
| Employees | N/A | 209 |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 497.9M | 514.3M |
| IPO Year | N/A | 2021 |
| Metric | CLMB | NPCE |
|---|---|---|
| Price | $102.13 | $15.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $136.00 | $18.00 |
| AVG Volume (30 Days) | 84.2K | ★ 196.0K |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | ★ 0.66% | N/A |
| EPS Growth | ★ 26.05 | N/A |
| EPS | ★ 4.64 | N/A |
| Revenue | ★ $620,431,000.00 | $94,864,000.00 |
| Revenue This Year | $37.27 | $24.82 |
| Revenue Next Year | $4.75 | $0.77 |
| P/E Ratio | $22.13 | ★ N/A |
| Revenue Growth | ★ 51.09 | 24.08 |
| 52 Week Low | $88.90 | $7.56 |
| 52 Week High | $145.02 | $18.98 |
| Indicator | CLMB | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 38.68 | 49.90 |
| Support Level | $101.90 | $15.29 |
| Resistance Level | $110.50 | $16.33 |
| Average True Range (ATR) | 3.68 | 0.56 |
| MACD | -0.24 | -0.25 |
| Stochastic Oscillator | 11.55 | 12.67 |
Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.